MCL1 and B-cell chronic lymphocytic leukemia: Since inhibition of Mcl-1 is effective in CLL cells and the Mcl-1 antagonist, AMG-176, has been demonstrated to induce apoptosis in CLL setting (20), we evaluated the combination of venetoclax with AMG-176 to impair trisomy 12 CLL cell viability.